153 related articles for article (PubMed ID: 12562447)
1. Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD).
Zentilin P; Dulbecco P; Bilardi C; Gambaro C; Iiritano E; Biagini R; Mela GS; Tessieri L; Mele MR; Mansi C; Pandolfo N; Vigneri S; Savarino V
Aliment Pharmacol Ther; 2003 Feb; 17(3):353-9. PubMed ID: 12562447
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori infection is not involved in the pathogenesis of either erosive or non-erosive gastro-oesophageal reflux disease.
Zentilin P; Iiritano E; Vignale C; Bilardi C; Mele MR; Spaggiari P; Gambaro C; Dulbecco P; Tessieri L; Reglioni S; Mansi C; Mastracci L; Vigneri S; Fiocca R; Savarino V
Aliment Pharmacol Ther; 2003 Apr; 17(8):1057-64. PubMed ID: 12694088
[TBL] [Abstract][Full Text] [Related]
3. The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis.
Gardner JD; Gallo-Torres H; Sloan S; Robinson M; Miner PB
Aliment Pharmacol Ther; 2003 Nov; 18(9):891-905. PubMed ID: 14616153
[TBL] [Abstract][Full Text] [Related]
4. Nocturnal gastric acidity pattern in gastro-oesophageal reflux disease with or without oesophagitis.
Sozzi M; Valentini M; Poletti M; Bertolissi E; Serraino D; Bovero E; De Iaco F
Ital J Gastroenterol; 1995; 27(8):413-8. PubMed ID: 8775466
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy.
Ando T; El-Omar EM; Goto Y; Nobata K; Watanabe O; Maeda O; Ishiguro K; Minami M; Hamajima N; Goto H
Gut; 2006 Feb; 55(2):158-64. PubMed ID: 16120761
[TBL] [Abstract][Full Text] [Related]
6. Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease.
Frazzoni M; De Micheli E; Savarino V
Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1091-8. PubMed ID: 14653828
[TBL] [Abstract][Full Text] [Related]
7. Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.
Martinez SD; Malagon IB; Garewal HS; Cui H; Fass R
Aliment Pharmacol Ther; 2003 Feb; 17(4):537-45. PubMed ID: 12622762
[TBL] [Abstract][Full Text] [Related]
8. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
Miner PB
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
[TBL] [Abstract][Full Text] [Related]
9. Review article: gastric pH -- the most relevant predictor of benefit in reflux disease?
Armstrong D
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():19-26; discussion 38-9. PubMed ID: 15456460
[TBL] [Abstract][Full Text] [Related]
10. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
Pace F; Bollani S; Molteni P; Bianchi Porro G
Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
[TBL] [Abstract][Full Text] [Related]
11. Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis.
Wu JC; Chan FK; Wong SK; Lee YT; Leung WK; Sung JJ
Aliment Pharmacol Ther; 2002 Mar; 16(3):545-52. PubMed ID: 11876709
[TBL] [Abstract][Full Text] [Related]
12. Eradication of Helicobacter pylori does not increase acid reflux in patients with mild to moderate reflux oesophagitis.
Tefera S; Hatlebakk JG; Berstad AE; Berstad A
Scand J Gastroenterol; 2002 Aug; 37(8):877-83. PubMed ID: 12229960
[TBL] [Abstract][Full Text] [Related]
13. Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.
DeVault KR
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():33-9. PubMed ID: 16483268
[TBL] [Abstract][Full Text] [Related]
14. Dysfunction of oesophageal motility in Helicobacter pylori-infected patients with reflux oesophagitis.
Wu JC; Lai AC; Wong SK; Chan FK; Leung WK; Sung JJ
Aliment Pharmacol Ther; 2001 Dec; 15(12):1913-9. PubMed ID: 11736722
[TBL] [Abstract][Full Text] [Related]
15. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease.
Cicala M; Emerenziani S; Caviglia R; Guarino MP; Vavassori P; Ribolsi M; Carotti S; Petitti T; Pallone F
Aliment Pharmacol Ther; 2003 Sep; 18(6):605-13. PubMed ID: 12969087
[TBL] [Abstract][Full Text] [Related]
16. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
[TBL] [Abstract][Full Text] [Related]
17. Manometric and pH-metric features in gastro-oesophageal reflux disease patients with and without Helicobacter pylori infection.
Manes G; Esposito P; Lioniello M; Bove A; Mosca S; Balzano A
Dig Liver Dis; 2000; 32(5):372-7. PubMed ID: 11030180
[TBL] [Abstract][Full Text] [Related]
18. Impaired egress rather than increased access: an important independent predictor of erosive oesophagitis.
Jones MP; Sloan SS; Jovanovic B; Kahrilas PJ
Neurogastroenterol Motil; 2002 Dec; 14(6):625-31. PubMed ID: 12464084
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic appearance of GERD: putative role of cell proliferation.
Calabrese C; Trerè D; Fabbri A; Cenacchi G; Vici M; Derenzini M; Di Febo G
Dig Liver Dis; 2007 Aug; 39(8):713-9. PubMed ID: 17606421
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea.
Kim N; Lee SW; Cho SI; Park CG; Yang CH; Kim HS; Rew JS; Moon JS; Kim S; Park SH; Jung HC; Chung IS;
Aliment Pharmacol Ther; 2008 Jan; 27(2):173-85. PubMed ID: 17973646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
